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ABSTRACT
Objectives: Studies have shown a shortening of the menstrual cycle following light exposure
in women with abnormally long menstrual cycles or with winter depression, suggesting that
artificial light can influence reproductive hormones and ovulation. The study was designed to
investigate this possibility.
Design: Placebo-controlled, crossover, counterbalanced order.
Setting: Medical centres and participants’ homes in Novosibirsk (558N), Russia.
Participants: Twenty-two women, aged 19–37 years, with baseline menstrual cycle length
28.1–37.8 d and no clinically evident endocrine abnormalities completed the study. The study
lasted for two menstrual cycles separated by at least one off-protocol cycle.
Interventions: During one experimental cycle, bright light was administered at home for 1
wk with a light box emitting white light at 4,300 lux at 41 cm for 45 min shortly after
awakening. During the other experimental cycle, dim light was ,100 lux at 41 cm with a one-
tube fluorescent source.
Outcome Measures: Blood samples and ultrasound scans were obtained in the afternoon
before and after the week of light exposure, on day ;7 and 14 after menstruation onset.
Further ultrasound scans after day 14 documented ovulation. Serum was assayed for thyroid-
stimulating hormone (TSH), prolactin (PRL), luteinizing hormone (LH), follicle-stimulating
hormone (FSH), and estradiol (E2).
Results: Concentrations of PRL, LH, and FSH were significantly increased with bright versus
dim light exposure, as was follicle size (ANOVA, intervention3day, p¼0.0043, 0.014, 0.049, and
0.042, respectively). The number of ovulatory cycles increased after exposure to bright
compared to dim light (12 versus 6 cycles, Wilcoxon tied p ¼ 0.034).
Conclusions: Morning exposure to bright light in the follicular phase of the menstrual cycle
stimulates the secretion of hypophyseal reproductive hormones, promotes ovary follicle
growth, and increases ovulation rates in women with slightly lengthened menstrual cycles. This
might be a promising method to overcome infertility.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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PLoS CLINICAL TRIALSINTRODUCTION
Artiﬁcial (ocular) light administered at the appropriate time
of day is used to overcome a variety of conditions associated
with circadian rhythm abnormalities (shift work, jet lag, sleep
disturbances), monthly cycles (premenstrual dysphoric dis-
order), seasonal variations (winter depression, bulimia nerv-
osa), amongst others [1]. Forty years ago it was asserted that
light might regulate the menstrual cycle and ovulation [2]. A
series of six studies—one in the Boston area, four in San
Diego, and one in Novosibirsk (1965–1995)—have shown that
the menstrual cycle shortened in women with long menstrual
cycles after bedside light administered overnight around the
days of presumed ovulation [3–7]. Two subsequent studies
found an increased rate of ovulation determined with a home
dip-stick test detecting an ovulatory surge of LH in urine ([8],
Putilov et al., unpublished data]. Additional evidence came
from a group of patients with seasonal affective disorder who
received conventional morning bright light therapy or dawn
simulation for a week starting within 0–13 days after
menstruation onset. This resulted in a shorter menstrual
cycle by 1.2 days on average, and the effect was not correlated
with the depression improvement [9].
The above studies were not accompanied by the hormonal
measurements that might elicit the mechanisms underlying
the cycle-shortening effect of light. Surprisingly, there has
been little investigation in humans into the effects of light on
the two principal hormones regulating the menstrual cycle—
follicle-stimulating hormone (FSH) and luteinizing hormone
(LH)—compared with other hypophyseal hormones and
melatonin. These studies showed an increase of LH and/or
FSH, in men or women, following bright light 500 to 3,000 lux
[10–12].
The aim of this study was to answer conclusively whether
light can inﬂuence menstrual cycle and ovulation, and to
determine the underlying hormonal changes taking place.
The design combined several approaches used in previous
studies and advanced some of them. For example, ultrasound
scans were introduced as a method to objectively document
ovulation. Bright light, during wakefulness was used since it
has also been shown to shorten the menstrual cycle [9], does
not disturb sleep (as dim overnight lights might) and is better
studied (in terms of neuroendocrine effects). The dark season
and the hour immediately following wakening were chosen as
the exposure time since light stimulus is most effective when
contrasted with low levels of light in the preceding period
(e.g., [13]). Women with slightly lengthened menstrual cycles
were selected with a view to shortening the cycle, i.e., a sort of
treatment since in woman with normal cycles this shortening
could be undesirable [9]. On the other hand, women with very
long menstrual cycles (mean .42 d) are only slightly
responsive to light exposure [7], suggesting that signiﬁcant
hormonal abnormalities are not subject to a relatively subtle
intervention such as light therapy.
METHODS
Participants
The study was performed in Novosibirsk (558N), in three
consecutive years 2003–2006, between October and April (the
shortest day is 7 h). Test participants were recruited via
advertisements in a local newspaper and a patient database of
the gynaecologist (EAS). The advertisement was as follows:
‘‘Women with lengthened menstrual cycles (30–38 days) are
invited to participate in a study. Ultrasound and hormonal
investigations will be conducted free of charge’’. Respondents
provided dates of menstruation onset over the past year and
suitable candidates were invited for clinical interview. During
the interview with the investigators (both are clinicians), they
received a detailed description of the study, completed a
questionnaire concerning their general health and answered
some medical questions from the clinicians. The inclusion
criteria required that the majority of menstrual cycles,
especially the last two baseline cycles, were free from any
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Editorial Commentary
Background: It is not clear whether light plays any role in determining
menstrual cycles or ovulation in women. However, light is used as a
treatment for some medical conditions related to rhythm, most notably
seasonal affective disorder. In this study, the researchers wanted to
examine the role of light in influencing the menstrual cycle. In the trial
reported here, 22 women with lengthened menstrual cycles were
provided with a light box that emitted either bright light or dim light,
and the women were asked to use the light box for a defined period
each day for one menstrual cycle. The study had a crossover design,
where women would receive either bright or dim light for one cycle,
then another cycle without the light box, and finally a cycle with either
bright or dim light, whichever they did not receive first. Outcomes
assessed in the trial included measurements of the blood levels of certain
hormones. Specifically, the researchers looked at three hormones that
determine the reproductive cycle (lutenizing hormone [LH], follicle
stimulating hormone [FSH], and prolactin); these are produced by a
region of the brain that is controlled by the hypothalamus, a gland that
is directly responsive to light. Additionally, ultrasound scans were used
to check for ovulation during each cycle. The trial was carried out in
winter in Novosibirsk, a Russian city.
What the trial shows: When the researchers compared hormone levels
between the ‘‘bright light’’ and ‘‘dim light’’ phases of the study, they
found statistically significant increases in levels of LH, FSH, and prolactin
in the blood. Ovulation was more likely in the ‘‘bright light’’ phase of the
study as compared to the ‘‘dim light’’ phase. However, levels of two
other hormones, thyroid stimulating hormone, and estradiol, were not
significantly different when comparing the ‘‘bright’’ and ‘‘dim’’ cycles.
Strengths and limitations: In this trial the use of a crossover design
enabled each woman to act as her own control, thereby reducing the
number of participants that were needed in the trial. A further strength
in this study was the use of ultrasound scans to allow the researchers to
pinpoint ovulation in the participants; similar studies have not tried to
examine the effects of light both on reproductive hormones and
ovulation. A weakness of the design is that participants were assigned to
receive either dim light first or bright light first using alternation, not true
randomization. Therefore blinding was not possible and the researchers
recruiting participants would have known in advance what intervention
each participant would receive first. Other weaknesses include the
limited number of participants in this study, and the nature of the
participant population, all of whom had lengthened menstrual cycles
and were living at fairly northerly latitude.
Contribution to the evidence: This study adds data suggesting that in
women with lengthened menstrual cycles, ovulation can be stimulated
by bright light. However, this finding would need to be replicated in a
larger sample of women and it is not yet clear whether bright light will
have the same effect on ovulation in women outside northerly latitudes
and with average-length menstrual cycles.
The Editorial Commentary is written by PLoS staff, based on the reports of the
academic editors and peer reviewers.medication known to interfere with hormone release; the
absence of clinically evident endocrine abnormalities; good
general health; a normal sleep-wake regimen; and no trans-
meridian travel two months prior to the study.
After meeting the inclusion criteria, the candidates signed
the consent form if they were willing to participate. The most
common motive for participation was long-standing difﬁculty
in conceiving and/or a physician’s recommendation for a
hormonal investigation, which is expensive. The consent
included the statement: ‘‘The agreement provides the
participant with free testing and is offered on a mutually
beneﬁcial basis: the participants receive information regard-
ing their reproductive system, whilst the clinicians are able to
investigate the effects of light’’. The study was approved by
the Ethics Committee of the Institute of Internal Medicine SB
RAMS.
Protocol
The study lasted for two menstrual cycles separated by an off-
protocol episode of at least one menstrual cycle. Bright light
was administered during one experimental cycle, dim light
during the other (placebo-controlled, crossover, counter-
balanced order design). Light treatment lasted for a week at
home and was preceded by the day of baseline investigations
and followed by the day of follow-up investigation. Both the
baseline and follow-up investigations were planned to be
performed in follicular phase before ovulation, because the
dominant follicle ruptures and the hormonal proﬁle changes
very considerably on ovulation and this might confound
consistency of our results, especially if not all cycles are
ovulatory. On the other hand, light exposure is most effective
when administered around the days of presumed ovulation
[7]. Therefore, the approximate day for entering the study
was calculated as minimal cycle length (for a particular
woman) minus 14 d (usual duration of the luteal phase) and
minus 7 d (duration of the light treatment). Participants came
to a medical centre in the afternoon to give 5 ml of 3-h fasted
venous blood and to pass an ultrasound examination. They
took a light device and a diary back home to start daily light
exposure the next morning, and returned a week later (on the
day of the last light exposure) for the follow-up examination.
For simplicity, baseline and follow-up examination days are
referred to in the text as ‘‘day 7’’ and ‘‘day 14’’. Ultrasound
scans were conducted as required to document ovulation and
participants also recorded post-awakening rectal temper-
ature daily in their diary to pinpoint the date.
Interventions
As in study [9], Sunray2-Max box (Outside In) was used to
provide bright white light of intensity 4,300 lux. The lamps
have a phosphor type 835 with a correlated colour temper-
ature of 3,500 K (Figure 1). The participant was instructed to
sit at a distance of 41 cm facing the screen of the box for 45
min shortly after waking. It was not necessary to look at the
screen all the time, just to allow light to freely enter both eyes.
Dim light (placebo control) was of normal room intensity less
than 100 lux at 41 cm from a domestic 1-tube ﬂuorescent
ﬁtting. After each week of light intervention, the participant
was invited to comment on their experience of using light. No
speciﬁc monitoring of adverse events was done (e.g. eye
examination) because the light is known to be a low-risk
intervention [1].
Objectives
The objective of the study was to investigate the inﬂuence of
morning bright light on ovarian function in women.
Outcomes
Blood was drawn from the antecubital vein, centrifuged
within 1 h, and the serum was kept frozen until the hormonal
assay. Serum was assayed for concentrations of thyroid-
stimulating hormone (TSH), prolactin (PRL), LH, FSH by
immunoluminometric assay (ILMA), and for estradiol (E2) by
ELISA. Reagent ILMA kits were obtained from Immunotech
(http://www.beckmancoulter.com/products/pr_immunolo-
gy.asp), and ELISA kits from DRG (http://www.drg-diagnostics.
de). The samples from each individual were assayed in the
same run, using one kit, to avoid interassay variability. The
sensitivity of the assay and maximal intra-assay variations
within the normal range of hormone were: 0.03 mU/l and
6.2% for TSH, 0.26 ng/ml and 3.4% for PRL, 0.2 U/l and 5.6%
for LH, 0.2 U/l and 2.9% for FSH, 9.7 pg/ml and 6.8% for E2.
Based on the literature, TSH and PRL are secreted in a
rhythmic fashion with an increase at night-time and relatively
stable values during an afternoon trough, whereas LH, FSH,
and E2 have no distinct 24-h variations (e.g., [14]). Blood was
taken in the afternoon in order to exclude any confounding
effect on the results of any phase shift of the hormone’s
circadian rhythm by repeated light stimuli. Since LH shows
pulsatile secretion during the day (e.g., [15]), a half-day urine
sample was collected in a subset of participants, to be
analysed in the event of near-signiﬁcant results on serum LH.
Ultrasound examination was performed using a linear/
sector ultrasonic compound scanner SSD-500 (Aloka [http://
www.aloka.com/]) with 3.5-MHz transabdominal and 5-MHz
Figure 1. Spectral Composition of the Bright Light
The figure shows a spectral power distribution of the light emitted from a
Sunray2-Max box (Outside In). It uses phosphor type 835 lamps (data from
Sylvania Lighting). The short wavelength up to ;450 nm was significantly
attenuated by the diffuser (filter characteristic from Interlux).
doi:10.1371/journal.pctr.0020007.g001
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and endometrium thickness were estimated and the scan
images/results printed. Follicle growth was determined as the
difference in diameter of the maximal (dominant) follicle on
day 14 and maximal follicle in the same ovary on day 7. The
disappearance of a dominant follicle in subsequent scans
indicated that ovulation had occurred. The presence of free
ﬂuid behind the uteri helped to show ovulation had occurred
recently, and an increase in echo signal from the endome-
trium conﬁrmed the transition from preovulatory to post-
ovulatory phase.
Sample Size
No formal sample size calculation was done. In the previous
light exposure studies, 8 to 27 participants were analysed
regarding menstrual cycle length [3–8], 27 and 13 regarding
ovulation ([8], Putilov et al., unpublished data), and 11 to 17
subjects regarding the hormones of main interest LH and
FSH [10–12]. With our crossover design, we aimed to have at
least 15 participants complete the study, targeting 20–25 to
either obtain a deﬁnitive conclusion within two years, or
possibly to halt the study after one year if interim analysis of
the results showed no signiﬁcance. In fact, the study period
was extended to three years because of operational problems.
Randomization
Entering the study was determined by participants’ menstrual
cycle onset and, therefore, was sequential and not dependent
on investigators. The type of light intervention was allocated
to participants alternately: the ﬁrst received dim light; the
next, bright light; the third, dim; etc. Alternating in this way
helped to better balance between months (seasons) and also
utilized fewer light devices.
Blinding
The study participants were not told whether they were to
received dim or bright light ﬁrst and would have realised only
during the second experimental cycle. Additionally, an
interest in the study’s diagnostic tests rather than the
intervention helped to lower expectations regarding placebo
and active light effects. One of the investigators (EAS) was
blind to the intervention type.
Statistical Methods
Analysis of variance (ANOVA) with two repeated measures,
intervention (bright versus dim light) and day (day 7 versus
day 14), were the primary statistics in the study. Standard
deviations of the means are reported in the text and tables
while standard errors of the mean are in ﬁgures. Categorical
Figure 2. Participant Flow Chart
doi:10.1371/journal.pctr.0020007.g002
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analysed using nonparametric statistics.
RESULTS
Recruitment and Participant Flow
Participant ﬂow is shown in Figure 2. Recruitment took place
in September through November, 2003–2005. In the ﬁrst year,
six participants were recruited (ﬁve have ended); in the
second, 8 (5); in the third, 13 (12). Of the 27 women that
entered the study, ﬁve failed to complete it due to pregnancy
(n ¼ 2), low cooperation (n ¼ 2), and moving away from the
area (n ¼ 1).
Baseline Data and Numbers Analyzed
The ﬁnal study group of 22 were aged 19 to 37 years (Table 1).
Based on diaries of the participants, the mean menstrual
cycle length ranged from 28.1 to 37.8 d, minimal cycle 26 to
32 days (median¼28 d), maximal cycle 30 to 56 days (median
¼ 38 days), 2–12 cycles analysed (median ¼ 8 cycles).
Actually, the participants entered the study on day 5–9
after menstruation onset (median ¼ 7 d, 1-d maximal
difference between the two experimental cycles, except in
two cases of 2 d). Light exposure started at 07:43 6 0:55 for
the dim light session versus 07:59 6 0:59 for the bright light
session (p¼0.069), with the individual difference between two
sessions less than 1 h in all but two women (median¼20 min).
The time lag between awakening and starting treatment was
similar: 16 6 14 min for the dim light versus 20 6 17 min for
the bright light (p ¼ 0.16). The maximal difference between
two blood sampling times on day 7 and day 14 was 2 h 45 min
(median ¼ 50 min).
Deviations of hypophyseal hormones from the normal
range were rare and mild in the studied group—not higher
than twice the upper limit and not below the lower limit. One
woman’s levels of TSH were consistently above the norm, i.e.,
for all four measurements, indicating a subclinical hypo-
thyroidism. Three women had increased values of PRL, one of
whom also had an episodic small increase in TSH and LH.
Two more women showed elevated LH or FSH during
baseline measurements. The ovarian hormone E2 was
typically around the lower limit of the normal range. Almost
all women had multifollicle ovaries by ultrasound scan,
indicating frequent anovulatory cycles [16]. None met
sufﬁcient criteria for polycystic ovary syndrome [17].
Outcomes and Estimation
The dynamics of the hormones’ concentrations, as well as
ovarian follicle growth following the repeated light stimuli,
are demonstrated in Figure 3; the statistics are summarized in
Table 2. PRL, LH, FSH, and follicle diameter were signiﬁ-
cantly increased after bright light compared to the dim light
whereas the changes in TSH, E2, and ovary volume were not
signiﬁcantly different between the two conditions. LH and E2
levels, and follicle and ovary sizes, were all signiﬁcantly
augmented after either bright or dim light (p , 0.01,
Student’s paired t-test), reﬂecting the normal dynamics
through the follicular phase, whereas PRL concentration
increased only after bright light (p ¼ 0.0021). Post-treatment
LH and FSH levels were within the norms for the preovula-
tory phase (except three cases of high LH after bright light),
and PRL remained less than twice the upper limit.
Separately analyzing the general ANOVA independent
factors ‘‘order of treatment’’ (exactly half of the participants
started the study with dim light ﬁrst), ‘‘seasonality’’ (exactly
half of the participants reported feeling worse in winter
versus summer in the screening questionnaire), and ‘‘start
month’’ (12 participants started the study before November)
did not reveal any signiﬁcant effect of these factors (either
main or at interaction with repeated measures ‘‘intervention’’
and ‘‘day’’) on the above outcomes.
The number of ovulatory cycles was higher with bright
versus dim light (12 versus six cycles). Distribution was as
.......................................................................................................................................................................................
Table 1. Baseline Characteristics of Women Completing the Study (n ¼ 22)
Variable Category Mean or Median
a 6 SD (Range) Number Percentage
Age 25.2 6 5.3 y (19–37 y)
Ethnicity Russian n ¼ 22 100%
Education High school finished n ¼ 52 3 %
In progress n ¼ 83 6 %
Relationship status Married n ¼ 11 50%
Long-term relationship n ¼ 83 6 %
Single n ¼ 31 4 %
Menstrual cycles length 32.6 6 2.6 d (28.1–37.8 d)
Minimal
a 28 d (26–32 d)
Maximal
a 38 d (30–56 d)
Normal length 21–35 d n ¼ 73 2 %
Parity Previously pregnant n ¼ 11 50%
Previously given birth n ¼ 73 2 %
Infertility (secondary) n ¼ 52 3 %
Body mass index 20.8 6 2.6 kg/m
2 (17.6–32.0 kg/m
2)
,18.5 kg/m
2 n ¼ 41 8 %
 25.0 kg/m
2 n ¼ 29 %
Hirsutism n ¼ 00 %
Seasonality (feeling worse in winter versus summer) n ¼ 11 50%
aMeans reported for all categories except minimal and maximal menstrual cycle length, which are reported as medians with ranges.
SD, standard deviation.
doi:10.1371/journal.pctr.0020007.t001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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light cycles; nine had anovulatory cycles in both experimental
conditions; one ovulated during the dim but not bright light
cycle; and seven vice versa (tied p ¼ 0.034, Wilcoxon test).
Menstrual cycle length was not signiﬁcantly different
between dim versus bright light (33.2 6 4.8 d versus 32.7 6
5.6 d, n ¼ 20; tied p ¼ 0.71, Wilcoxon test). Two menstrual
cycles were missed from the analysis because of pregnancies
during the second-order experimental cycle (Figure 2).
Ancillary Analyses
In total, four women became pregnant during the study
period (though all were asked to use condoms during
intercourse)—three during the bright light experimental
cycle and one during the dim light cycle. In the ﬁrst three
women, ovulation occurred at days 17–18 of the cycle, shortly
after the light treatment ended. In the fourth case conception
occurred late: at day 24, the dominant follicle was still not
present, and the ultrasound examination was stopped. The
prospective ultrasound scan 32 d later (because of absence of
menstruation) and the temperature data suggested ovulation
occurred on day ;34. All pregnancies were desired.
Numerous signiﬁcant intercorrelations were found be-
tween the studied hormones, follicle growth and ovary
volume after light stimuli (n ¼ 44), all of which were direct
and many predictable. For example, changes in PRL, LH,
FSH, and E2 all intercorrelated (p , 0.05), the strength being
maximal between LH and FSH (p , 0.001); the only exception
was no link between the changes in FSH and E2. The change
in E2 most strongly correlated with the growth of the ovarian
follicle (p , 0.001) and with ovulation occurrence (p ¼ 0.006,
Spearman’s correlation test) which is to be expected, since
most of the E2 is secreted by growing follicles.
Adverse Events
There were no adverse effects except two reports of transient
mild eye strain known to occur during bright light therapy
[1].
DISCUSSION
Interpretation
The study showed that PRL, LH, and FSH secretions, and
ovarian follicle growth and the likelihood of ovulation are all
increased following a week of morning bright light exposure
compared with dim light administered to the same women, in
the follicular phase of their cycles. The change of TSH and E2
secretions was not signiﬁcantly different between two
conditions.
This is the ﬁrst study to focus on the effect of light on the
ovulatory process with concomitant measurement of several
hormones to understand the underlying mechanism. It is
clear that the increased rate of ovulation following bright
light exposure is a consequence of faster follicle maturation.
Follicle maturation, in turn, is determined by the complex
interrelated changes in the secretion of pituitary-ovarian
hormones. The neuroanatomical basis for the effect of light
may include the novel melanopsin-based photoreceptors in
the eye conveying information via the retinohypothalamic
tract (separate from the optic nerve) to the biological clock in
the suprachiasmatic nucleus of the hypothalamus (reviewed
in [18]). There are likely to be numerous other links from the
hypothalamus, yet the pathway to the pineal gland—secreting
the darkness neurohormone melatonin—is the only one well
studied. However, contrary to animal ﬁndings, there is no
solid evidence that melatonin plays a signiﬁcant role in the
modulation of the human reproductive function (summar-
ized in [19]). Light may act directly on the hypothalamic-
pituitary-ovarian axis as it might for the hypothalamic-
pituitary-adrenal axis [20]. The neuroendocrine mechanism
involved in the stimulatory effect of light may be different
from those regulating the monthly increase of LH and FSH
during the follicular phase. To illustrate this, in Japanese
quail barbiturate anaesthesia, which blocks an LH surge
Figure 3. Dynamics of Hormones Secretion and Ovarian Follicle Size
following a Week of Bright Light Exposure
Twenty-two women with slightly lengthened menstrual cycles were exposed
to bright or dim ocular light (45 min after waking, daily, for 1 wk between
days ;7 and 14 after menstruation onset, i.e., before ovulation) during two
different menstrual cycles. Prolactin, luteinizing hormone (LH), follicle-
stimulating hormone (FSH), and ovarian follicle size were significantly (*)
increased in with bright versus dim light. The changes in thyroid-stimulating
hormone (TSH) and estradiol levels were not significantly different between
the two conditions (ANOVA, intervention 3 day interaction). Error bars
indicate standard errors of the mean.
doi:10.1371/journal.pctr.0020007.g003
.......................................................................................
Table 2. Main Outcomes and Statistical Testing for Compar-
isons between the Effects of Bright versus Dim Light
Outcome DD
a 95% Confidence Interval p-Value
TSH 0.25 mU/l  0.22 to 0.72 mU/l 0.28
PRL 4.9 ng/ml 1.7 to 8.1 ng/ml 0.0043
LH 9.3 U/l 2.1 to 16.5 U/l 0.014
FSH 1.8 U/l 0.0 to 3.6 U/l 0.049
E2 29.8 pg/ml  7.6 to 67.3 pg/ml 0.11
Follicle size 3.4 mm 0.1 to 6.7 mm 0.042
aDD is a difference between the changes at bright versus dim light.
doi:10.1371/journal.pctr.0020007.t002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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during ovulatory cycle, did not block the preovulatory-like
increase of LH induced by light [21].
Generalisability
The effects of light discussed here should not be generalized
to women with normal or very long/irregular menstrual cycles
(as these groups are likely to have different endocrinology
from that of the study participants), or to the summer season
and Southern locations (both providing bright rather than
dark conditions).
Overall Evidence
The literature search was done via our own database of
publications on the topic, PubMed (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?DB¼pubmed), and local libraries, with
e-mail inquiries to the authors on speciﬁc questions, if
necessary. Only four previous experiments have investigated
the effect of artiﬁcial light on the reproductive hormones LH,
FSH, and E2 in humans, and those results are in line with
ours. In a crossover, placebo-controlled study of LH
excretion, the 24-h LH level was increased after morning
bright light 1,000 lux administered to 11 healthy men
between 05:00 and 06:00 for 5 d [12]. Miyauchi et al. [10]
investigated the effect of an acute light stimulus (3,000 lux
presented between 22:40 and 24:00) on ﬁve women in their
follicular phases and found an increase of LH and FSH
compared to prestimulus levels 21:30–22:40. In the reference
group of six participants without light, there was no change
in hormone concentrations. In a subsequent study [11] the
serum concentration of FSH was increased at 02:00 (n ¼ 17),
but not at 22:00 following light stimulus of 500–800 lux
presented from 17:30 to 02:00; the change in LH did not
reach a signiﬁcance threshold (the authors suggested this may
be because of LH pulsatility). Graham et al. [22] found no
change in all-night E2 levels in 22 women exposed to bright
light 5,200 lux from 21:00 to 01:00. The changes in
reproductive hormones resemble a natural increased pitui-
tary–ovarian axis activity in spring found in one [23] but not
all studies performed in Finland [24,25].
TSH secretion is generally rigidly coupled to artiﬁcial light
exposure (e.g., [26]) as was the case in our study. The ﬁndings
on PRL in healthy participants are not consistent. In two
studies, plasma PRL concentrations were increased, either
during evening bright light [10] or after morning light
exposure [27]. In others, PRL levels were unaffected by night
light [28,29], and also after daily light exposure [30]. In some
studies, PRL levels were suppressed by light at night [11,31].
The low rate of ovulation (27%) in the studied group is not
surprising as menstrual cycles of over 35 days are associated
with low rates of conception in a signiﬁcant number of women
[32]. We did not ﬁnd a signiﬁcant shortening of the menstrual
cycle following light exposure. Whilst this was also the case in
the last menstrual cycle study of the San Diego group [8], in
previous studies the shortening effect had been shown
consistently [3–7,9]. The cause of this discrepancy is unclear.
Study Limitations
The limited number of participants and somewhat narrow
sample population are the major limitations of the study.
Another consideration is that knowledge of the study results
after each of the two consecutive interim analyses may have
the potential to bias the results of the following year.
Conclusions
This study, using ultrasonographic examination and hormo-
nal assays, shows conclusively, to our knowledge for the ﬁrst
time, that ovulation may be successfully potentiated by
morning artiﬁcial bright light. This might be a promising
method to overcome infertility in some women.
SUPPORTING INFORMATION
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Found at doi:10.1371/journal.pctr.0020007.sd001 (44 KB DOC).
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